Clinical Trial Update: Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating bevacizumab for adults with recurrent respiratory papillomatosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Respiratory Tract Diseases, Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING